Synthesis, Characterization And Anticancer Activity Of Piperazine Substituted Porphyrins
Heping Li,Cancheng Guo,Jianming Ruan,Baiyun Huang
DOI: https://doi.org/10.3321/j.issn:0253-2786.2004.07.011
2004-01-01
Chinese Journal of Organic Chemistry
Abstract:A molecular design strategy was outlined for the synthesis of porphyrin-containing anticancer drugs. A series of six porphyrin monomers, 5,10,15,20-tetra[4-(4'-ethylpiperazinyl)phenyl]porphyrin (TEPPH2, 8a), 5, 10,15,20-tetra[4-(4'-butylpiperazinyl)phenyl]porphyrin (TBPPH2, 8b), 5,10,15,20-tetra[4-(4-heptylpiperazinyl)phenyl]porphyrin (THPPH2, 8c), 5,10,15,20-tetra[4-(.4'-phenylpiperazinyl)phenyl]porphyrin (TPhPPH2, 8d), 5-[4-(4'-ethylpiperazinyl) phenyl ] -10, 15, 20-triphenylporphyrin ( EPTPPH2, 8e) and 5-[ 4-(4'-butylpiperazinyl)phenyl ] -10, 15, 20- triphenylporphyrin ( BPTPPH2, 8f), have been prepared by the direct condensation of substituted benzaldehydes with pyrrole. Each porphyrin bears one or four substituted piperazine moieties that have been used as drugs. Their structures were characterized by elemental analysis, MS, H-1 NMR, IR and UV-vis spectra. The preliminary investigation of anticancer activity of these porphyrins showed that the porphyrins might have potential application in medicine owing to their special biological activity.